Literature DB >> 19914855

Applications of small molecule BMP inhibitors in physiology and disease.

Charles C Hong1, Paul B Yu.   

Abstract

Bone morphogenetic proteins (BMPs) provide critical signals for determining cell fate, specifying gastrulation, embryonic patterning, organogenesis, and the remodeling of diverse tissues. Recent work has suggested that in addition to coordinating pivotal events in development, BMPs may also regulate certain homeostatic physiological processes independently of effects on cell growth or differentiation. We recently described the identification of dorsomorphin, a small molecule inhibitor of BMP type I receptors which inhibits BMP signaling in preference to TGF-beta, Activin, and other ligands of the TGF-beta family. We describe a number of strategies using dorsomorphin and its derivatives as probes to assess the physiologic roles of BMP signaling. We also discuss several potential applications for small molecule BMP inhibitors, including stem cell manipulation, and the therapeutic modification of bone remodeling, heterotopic ossification, and iron homeostasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19914855      PMCID: PMC2813719          DOI: 10.1016/j.cytogfr.2009.10.021

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  70 in total

1.  In vivo somatic cell gene transfer of an engineered Noggin mutein prevents BMP4-induced heterotopic ossification.

Authors:  David L Glaser; Aris N Economides; Lili Wang; Xia Liu; Robert D Kimble; James P Fandl; James M Wilson; Neil Stahl; Frederick S Kaplan; Eileen M Shore
Journal:  J Bone Joint Surg Am       Date:  2003-12       Impact factor: 5.284

2.  Synthesis and initial SAR studies of 3,6-disubstituted pyrazolo[1,5-a]pyrimidines: a new class of KDR kinase inhibitors.

Authors:  Mark E Fraley; William F Hoffman; Robert S Rubino; Randall W Hungate; Andrew J Tebben; Ruth Z Rutledge; Rosemary C McFall; William R Huckle; Richard L Kendall; Kathleen E Coll; Kenneth A Thomas
Journal:  Bioorg Med Chem Lett       Date:  2002-10-07       Impact factor: 2.823

3.  lgtC expression modulates resistance to C4b deposition on an invasive nontypeable Haemophilus influenzae.

Authors:  Derek K Ho; Sanjay Ram; Kevin L Nelson; Paul J Bonthuis; Arnold L Smith
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

4.  Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.

Authors:  Brian T Feeley; Lucie Krenek; Nancy Liu; Wellington K Hsu; Seth C Gamradt; Edward M Schwarz; Johnny Huard; Jay R Lieberman
Journal:  Bone       Date:  2005-08-26       Impact factor: 4.398

5.  Repulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4.

Authors:  Yin Xia; Paul B Yu; Yisrael Sidis; Hideyuki Beppu; Kenneth D Bloch; Alan L Schneyer; Herbert Y Lin
Journal:  J Biol Chem       Date:  2007-05-01       Impact factor: 5.157

6.  BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway.

Authors:  Nobuhiro Kamiya; Ling Ye; Tatsuya Kobayashi; Yoshiyuki Mochida; Mitsuo Yamauchi; Henry M Kronenberg; Jian Q Feng; Yuji Mishina
Journal:  Development       Date:  2008-10-16       Impact factor: 6.868

7.  Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily.

Authors:  N P Barbara; J L Wrana; M Letarte
Journal:  J Biol Chem       Date:  1999-01-08       Impact factor: 5.157

8.  Retroviral delivery of Noggin inhibits the formation of heterotopic ossification induced by BMP-4, demineralized bone matrix, and trauma in an animal model.

Authors:  David Hannallah; Hairong Peng; Brett Young; Arvydas Usas; Brian Gearhart; Johnny Huard
Journal:  J Bone Joint Surg Am       Date:  2004-01       Impact factor: 5.284

9.  Design and synthesis of 3,7-diarylimidazopyridines as inhibitors of the VEGF-receptor KDR.

Authors:  Zhicai Wu; Mark E Fraley; Mark T Bilodeau; Mildred L Kaufman; Edward S Tasber; Adrienne E Balitza; George D Hartman; Kathleen E Coll; Keith Rickert; Jennifer Shipman; Bin Shi; Laura Sepp-Lorenzino; Kenneth A Thomas
Journal:  Bioorg Med Chem Lett       Date:  2004-02-23       Impact factor: 2.823

10.  Role of RGM coreceptors in bone morphogenetic protein signaling.

Authors:  Peter J Halbrooks; Ru Ding; John M Wozney; Gerard Bain
Journal:  J Mol Signal       Date:  2007-07-05
View more
  52 in total

1.  Evidence for constitutive bone morphogenetic protein-2 secretion by M1 macrophages: Constitutive auto/paracrine osteogenic signaling by BMP-2 in M1 macrophages.

Authors:  Prabhatchandra R Dube; Lutz Birnbaumer; Guillermo Vazquez
Journal:  Biochem Biophys Res Commun       Date:  2017-07-12       Impact factor: 3.575

2.  Disruption of lineage specification in adult pulmonary mesenchymal progenitor cells promotes microvascular dysfunction.

Authors:  Christa F Gaskill; Erica J Carrier; Jonathan A Kropski; Nathaniel C Bloodworth; Swapna Menon; Robert F Foronjy; M Mark Taketo; Charles C Hong; Eric D Austin; James D West; Anna L Means; James E Loyd; W David Merryman; Anna R Hemnes; Stijn De Langhe; Timothy S Blackwell; Dwight J Klemm; Susan M Majka
Journal:  J Clin Invest       Date:  2017-05-02       Impact factor: 14.808

Review 3.  BMP signaling in vascular development and disease.

Authors:  Jonathan W Lowery; Mark P de Caestecker
Journal:  Cytokine Growth Factor Rev       Date:  2010-07-31       Impact factor: 7.638

4.  Development of an ALK2-biased BMP type I receptor kinase inhibitor.

Authors:  Agustin H Mohedas; Xuechao Xing; Kelli A Armstrong; Alex N Bullock; Gregory D Cuny; Paul B Yu
Journal:  ACS Chem Biol       Date:  2013-04-30       Impact factor: 5.100

5.  Hard targets for a second skeleton: therapeutic horizons for fibrodysplasia ossificans progressiva (FOP).

Authors:  Frederick S Kaplan; Robert J Pignolo; Mona M Al Mukaddam; Eileen M Shore
Journal:  Expert Opin Orphan Drugs       Date:  2017-03-17       Impact factor: 0.694

6.  Anti-inflammatory activity of bone morphogenetic protein signaling pathways in stomachs of mice.

Authors:  Hidehiko Takabayashi; Masahiko Shinohara; Maria Mao; Piangwarin Phaosawasdi; Mohamad El-Zaatari; Min Zhang; Tuo Ji; Kathryn A Eaton; Duyen Dang; John Kao; Andrea Todisco
Journal:  Gastroenterology       Date:  2014-04-18       Impact factor: 22.682

Review 7.  Bone Morphogenetic Proteins.

Authors:  Takenobu Katagiri; Tetsuro Watabe
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-06-01       Impact factor: 10.005

8.  Nascent Lung Organoids Reveal Epithelium- and Bone Morphogenetic Protein-mediated Suppression of Fibroblast Activation.

Authors:  Qi Tan; Xiao Yin Ma; Wei Liu; Jeffrey A Meridew; Dakota L Jones; Andrew J Haak; Delphine Sicard; Giovanni Ligresti; Daniel J Tschumperlin
Journal:  Am J Respir Cell Mol Biol       Date:  2019-11       Impact factor: 6.914

Review 9.  Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.

Authors:  Pawina Jiramongkolchai; Philip Owens; Charles C Hong
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

10.  Discovery, synthesis and characterization of a series of 7-aryl-imidazo[1,2-a]pyridine-3-ylquinolines as activin-like kinase (ALK) inhibitors.

Authors:  Darren W Engers; Sean R Bollinger; Andrew S Felts; Anish K Vadukoot; Charles H Williams; Anna L Blobaum; Craig W Lindsley; Charles C Hong; Corey R Hopkins
Journal:  Bioorg Med Chem Lett       Date:  2020-07-17       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.